APA (7th ed.) Citation

KR, T., JM, W., Y, L., HR, Q., F, G., MA, K., . . . FT, B. (2023). Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide. American journal of nephrology, 54(1-2), 74. https://doi.org/10.1159/000529374

Chicago Style (17th ed.) Citation

KR, Tuttle, Wilson JM, Lin Y, Qian HR, Genovese F, Karsdal MA, Duffin KL, and Botros FT. "Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide." American Journal of Nephrology 54, no. 1-2 (2023): 74. https://doi.org/10.1159/000529374.

MLA (9th ed.) Citation

KR, Tuttle, et al. "Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide." American Journal of Nephrology, vol. 54, no. 1-2, 2023, p. 74, https://doi.org/10.1159/000529374.